1.Superoxide Dismutase Activity in Down Syndrom.
Kun Soo LEE ; Ja Hoon KOO ; Kun Young SOHN
Journal of the Korean Pediatric Society 1986;29(4):13-19
No abstract available.
Superoxide Dismutase*
;
Superoxides*
2.Idiopathic hypercalciuria in children with hematuria.
Ki Young KOO ; Jong Ho LEE ; Cheol Woo KO ; Ja Hoon KOO
Korean Journal of Nephrology 1992;11(3):248-252
No abstract available.
Child*
;
Hematuria*
;
Humans
;
Hypercalciuria*
3.Vascular laboratory as a diagnostic tool for the peripheral vascular disease.
Sang Hoon LEE ; Kyung Hoi KOO ; Joong Bae SEO ; Han Koo LEE ; Young Sik MIN
The Journal of the Korean Orthopaedic Association 1993;28(7):2483-2490
No abstract available.
Peripheral Vascular Diseases*
4.Survival Rate after Pulmonary Metastasectomy in Bone and Soft Tissue Sarcoma.
Yong Koo KANG ; Seung Koo LEE ; Jung Man KIM ; Hoon Kyo KIM ; Kun Hyun CHO ; Young Hoon KIM
The Journal of the Korean Orthopaedic Association 1997;32(1):223-228
We investigated the overall survival rate after pulmonary metastasectomy in the bone and soft tissue sarcoma and the available prognostic factors related with the survival rate after pulmonary metastasectomy. Between 1986 and 1995, 9 patients (median age 32) with bone and soft tissue sarcoma with pulmonary metastasis were managed in the Catholic University of Korea. Until the final follow-up in May 1996, 6 patients have died of disease and their mean survival period was 28 months (9- 58months). The actual 5-year survival rate by Kaplan-Meier method was 33%. Prognostic factors such as tumor free interval, number of metastatic lesion, postoperative chemotherapy and histologic grade were analyzed. Three patients who had the tumor free interval over 3 years were alive (mean survival period: 52.6 months), whereas six patients who had the tumor free interval less than 3 years were dead (mean survival period: 19 months). Out of four patients with low grade tumor, three patients were alive with average 39.2 months survival period, whereas five patients with high grade tumor were all dead with average 19.2 months survival period. These results suggested that pulmonary metastasectomy in bone and soft tissue sarcoma may prolong the survival rate. The long tumor free interval, histological low grade and soft tissue sarcoma may influenced on prolonged survival rate. However, number of metastatic lesion or postoperative chemotherapy has not influenced on the survival rate.
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Korea
;
Metastasectomy*
;
Neoplasm Metastasis
;
Sarcoma*
;
Survival Rate*
5.Prevalence of hepatitis B and C viral markers in patients with hepatocellular carcinoma in Korea.
Byung Hoon HAN ; Sung Wook LEE ; Ja Young KOO ; Byung Chae PARK
Journal of the Korean Cancer Association 1991;23(4):723-727
No abstract available.
Biomarkers*
;
Carcinoma, Hepatocellular*
;
Hepatitis B*
;
Hepatitis*
;
Humans
;
Korea*
;
Prevalence*
6.Two Cases of Hemolytic Uremic Syndrome.
Sook Hee LEE ; Dong Jin LEE ; Ja Hoon KOO ; Doo Hong AHN ; Young Jin KIM
Journal of the Korean Pediatric Society 1984;27(4):384-389
No abstract available.
Hemolytic-Uremic Syndrome*
7.Chronic Renal Failure in Children.
Kyung Ok LEE ; Young Ho AHN ; Sang Bum LEE ; Ja Hoon KOO
Journal of the Korean Pediatric Society 1988;31(6):738-746
No abstract available.
Child*
;
Humans
;
Kidney Failure, Chronic*
8.An experimental study on the enhanced cytolytic effects of natural killer cells by interleukin 2.
Hoon Bae JEON ; Sang Yong CHOI ; Young Chul KIM ; Bum Hwan KOO
Journal of the Korean Surgical Society 1993;45(3):314-323
No abstract available.
Interleukin-2*
;
Interleukins*
;
Killer Cells, Natural*
9.A Case of Acute Lymphocytic Leukemia with Both Renal Enlargement.
Bok Hee OH ; Young Hoon SOUNG ; On Koo CHO ; Woo Gill LEE
Journal of the Korean Pediatric Society 1983;26(11):1149-1153
No abstract available.
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
10.Evaluation of function after shoulder fusion.
Han Koo LEE ; Sang Hoon LEE ; F LEE ; Young Do KOH
The Journal of the Korean Orthopaedic Association 1992;27(1):92-96
No abstract available.
Shoulder*